Viscosupplementation Market by Product (Five Injection, Single Injection, Three Injection), Source (Animal, Non-animal), Application, End-use - Global Forecast 2024-2030

[194 Pages Report] The Viscosupplementation Market size was estimated at USD 2.83 billion in 2023 and expected to reach USD 3.01 billion in 2024, at a CAGR 6.19% to reach USD 4.32 billion by 2030.

Viscosupplementation is a medical procedure involving the injection of hyaluronic acid into a joint, such as the knee, to relieve pain caused by conditions such as osteoarthritis. As a non-surgical treatment option, viscosupplementation aims to improve joint function, reduce pain, and possibly delay joint replacement surgery. Increasing incidences of joint disorders and sport-related injuries, a growing elderly population that is more susceptible to such ailments, and the rising preference for minimally invasive procedures significantly contribute to market growth. However, the existence of alternative treatment options, including steroid injections and non-pharmacologic therapies, may impede market growth. Nevertheless, technological advancements in formulating and delivering hyaluronic acid and healthcare infrastructure improvements are expected to create potential opportunities for developing the viscosupplementation market.

The market is evolving in the Americas owing to the growing incidence of osteoarthritis, high healthcare expenditure, increasing preference for minimally invasive procedures, and widespread availability of several FDA-approved HA products. Advanced healthcare systems, increased awareness about osteoarthritis treatment options, and supportive regulatory frameworks are encouraging the growth of the viscosupplementation market in Europe. The Middle East and Africa viscosupplementation market is growing with improving availability and affordability of treatment and the prevalence of competitive treatment modalities for osteoarthritis. The Asia Pacific region represents significant demand for viscosupplementation due to high osteoarthritis prevalence, expanding healthcare infrastructure, and increasing accessibility to advanced osteoarthritis treatments. Besides, ongoing research to improve the efficacy of viscosupplementation therapy is anticipated to propel the demand for the viscosupplementation market globally.

The five-injection regimen is a viscosupplementation treatment consisting of five hyaluronic acid (HA) injections. This course of therapy is typically administered once per week over five consecutive weeks. Primarily used for the management of knee osteoarthritis, this treatment aims to restore the lubricating and cushioning properties of the synovial fluid in the joint. The Single-Injection Regimen offers an alternative approach to viscosupplementation with the convenience of a one-time injection. This product is formulated with a high concentration of hyaluronic acid and often includes cross-linking agents that enhance the durability and longevity of the treatment within the joint. The Three-Injection Regimen is a widely adopted viscosupplementation treatment that involves a series of three hyaluronic acid injections. These are typically administered one week apart and are designed to supplement the viscous properties of synovial fluid in the joint space. The primary goal of this treatment is to relieve pain and enhance mobility in patients with osteoarthritis. The three-injection regimen strikes a balance between the more extensive five-injection course and the single-injection alternative, offering a middle ground in terms of treatment commitment and duration of symptom relief.

Animal-based sources have been the primary means of obtaining hyaluronic acid for viscosupplementation. Animal-based sources utilize tissues from rooster combs, which are rich in hyaluronic acid or are extracted from other avian tissues. Non-animal-based hyaluronic acid is produced through bacterial fermentation processes. Genetically modified strains of bacteria, such as Streptococcus zooepidemicus, are used to biosynthesize high-purity HA. Non-animal HA is considered safe and effective, eliminating the risks associated with avian proteins that can cause hypersensitivity reactions. Additionally, non-animal-based HA has been gaining popularity due to ethical considerations and consistency in production.

Hyaluronic acid is directly injected into the affected joint in the viscosupplementation treatment for hand osteoarthritis. This treatment is used when traditional non-surgical treatments such as pain medications and physical therapy have not provided adequate relief. The main benefit of viscosupplementation for hand osteoarthritis lies in its pain reduction and, hence, improvement in function and quality of life. Viscosupplementation is a proven therapeutic measure to alleviate pain and improve functionality in patients with hip osteoarthritis, particularly those not responding to conventional treatments. The procedure for the hip joint is more complex, often requiring ultrasound or X-ray guidance due to the hip's deep-seated nature. A key advantage of viscosupplementation in hip osteoarthritis is its superior safety profile compared to long-term use of non-steroidal anti-inflammatory drugs (NSAIDs). Knee osteoarthritis is the most common application for viscosupplementation since the knee is a major weight-bearing joint and, therefore, is highly susceptible to wear and tear. The viscosupplementation procedure aims to restore the natural properties of the synovial fluid lost to knee osteoarthritis.

Hospitals represent a significant end-use sector for viscosupplementation, a therapeutic option for patients suffering from osteoarthritis, particularly in the knee joint. As comprehensive medical facilities with a multidisciplinary approach, hospitals are pivotal in providing this minimally invasive procedure. Viscosupplementation involves the intra-articular injection of hyaluronic acid to lubricate the joint, alleviate pain, and improve mobility. Orthopedic clinics and Ambulatory Surgical Centers (ASCs) are specialized end-use settings where viscosupplementation is frequently administered. These centers are predominantly focused on musculoskeletal health, making them highly adept at providing targeted therapies like viscosupplementation. The convenience, efficiency, and typically lower costs associated with ASCs make them an attractive option for patients seeking outpatient care.

The market dynamics represent an ever-changing landscape of the Viscosupplementation Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Viscosupplementation Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Viscosupplementation Market.

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Viscosupplementation Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The value chain of the Viscosupplementation Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

The pricing analysis comprehensively evaluates how a product or service is priced within the Viscosupplementation Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Viscosupplementation Market.

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Viscosupplementation Market.

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Viscosupplementation Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

The trade analysis of the Viscosupplementation Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

The regulatory framework analysis for the Viscosupplementation Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Viscosupplementation Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Viscosupplementation Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

• KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis

  Kiomed Pharma and ARSYLAB have entered a strategic partnership to promote and distribute KIOMEDINEVS.ONE, a breakthrough treatment class for individuals suffering from refractory knee osteoarthritis in France. This innovative therapy represents a new direction in viscosupplementation, offering a promising option for patients. [Published On: 2023-09-17]

• Anika’s Cingal Successfully Achieves Primary Endpoint in Third Phase III Study

  Anika Therapeutics completed a Phase 3 clinical trial for its innovative product, CINGAL. CINGAL is specifically formulated to provide effective treatment for the symptoms of osteoarthritis through intra-articular viscosupplementation. The primary endpoint of the study clearly demonstrated that a single intra-articular injection of CINGAL outperformed placebo in improving patient symptom scores at the 24-week mark. [Published On: 2022-11-01]

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Viscosupplementation Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The report delves into recent significant developments in the Viscosupplementation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Anika Therapeutics, Inc., Avanos Medical, Inc., Bausch Health Companies Inc., Bioventus LLC, Contipro A.S., DePuy Synthes by Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Ferring B.V., Fidia Farmaceutici S.p.A., Gentex Pharma, LLC, LG Chem Ltd., Lifecore Biomedical, LLC, Quimfa S.A., Regen Lab SA, Sanofi S.A., Seikagaku Corporation, Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zimmer Biomet.

This research report categorizes the Viscosupplementation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Five Injection
  • Single Injection
  • Three Injection
• Source
  • Animal
  • Non-animal
• Application
  • Hand Osteoarthritis
  • Hip Osteoarthritis
  • Knee Osteoarthritis
• End-use
  • Hospitals
  • Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?